Submitted by Anonymous (not verified) on 5 January 2026 - 16:45
Human medicines European public assessment report (EPAR): Alymsys, bevacizumab, Date of authorisation: 26/03/2021, Revision: 10, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Alymsys, bevacizumab, Date of authorisation: 26/03/2021, Revision: 10, Status: Authorised